Journal of Inflammation Research,
Journal Year:
2021,
Volume and Issue:
Volume 14, P. 5337 - 5347
Published: Oct. 1, 2021
Purpose:
Clinically,
it
is
challenging
to
manage
diabetic
patients
with
periodontitis.
Biochemically,
both
involve
a
wide
range
of
inflammatory/collagenolytic
conditions
which
exacerbate
each
other
in
"bi-directional
manner."
However,
standard
treatments
for
this
type
periodontitis
rely
on
reducing
the
bacterial
burden
and
less
controlling
hyper-inflammation/excessive-collagenolysis.
Thus,
there
crucial
need
new
therapeutic
strategies
modulate
excessive
host
response
promote
enhanced
resolution
inflammation.
The
aim
current
study
evaluate
impact
novel
chemically-modified
curcumin
2.24
(CMC2.24)
inflammatory
rats.
Methods:
Type
I
diabetes
was
induced
by
streptozotocin
injection;
periodontal
breakdown
then
results
as
complication
uncontrolled
hyperglycemia.
Non-diabetic
rats
served
controls.
CMC2.24,
or
vehicle-alone,
administered
oral
gavage
daily
3
weeks
diabetics.
Micro-CT
used
analyze
morphometric
changes
quantify
bone
loss.
MMPs
were
analyzed
gelatin
zymography.
Cell
function
examined
cell
migration
assay,
cytokines
resolvins
measured
ELISA.
Results:
In
severe
disease
model,
administration
pleiotropic
CMC2.24
found
normalize
accumulation
impaired
chemotactic
activity
macrophages
peritoneal
exudates,
significantly
decrease
MMP-9
pro-inflammatory
near
normal
levels,
markedly
increase
resolvin
D
1
(RvD
)
levels
thioglycolate-elicited
exudates
(tPE).
Similar
effects
RvD
observed
non-elicited
resident
washes
(rPW).
Regarding
clinical
relevance,
inhibited
loss
alveolar
height,
volume
mineral
density
(ie,
diabetes-induced
osteoporosis).
Conclusion:
conclusion,
treating
hyperglycemic
(a
tri-ketonic
phenylaminocarbonyl
curcumin)
promotes
local
systemic
inflammation,
reduces
loss,
addition
suppressing
collagenolytic
cytokines,
suggesting
strategy
complicated
chronic
diseases.
Keywords:
hyperglycemia,
periodontitis,
matrix
metalloproteinases,
resolvins,
host-modulatory
therapy
Applied Sciences,
Journal Year:
2021,
Volume and Issue:
11(8), P. 3316 - 3316
Published: April 7, 2021
In
the
last
few
years,
role
of
oral
microbiota
in
setting
diseases
such
as
caries,
periodontal
disease,
cancer
and
systemic
infections,
including
rheumatoid
arthritis,
cardiovascular
disease
brain
abscess
(BA),
has
attracted
attention
physicians
researchers.
Approximately
5–7%
all
BAs
have
an
odontogenic
origin,
representing
important
pathological
condition
with
a
high
morbidity
mortality.
A
systematic
search
two
databases
(Pubmed
Ovid
EMBASE)
was
performed
for
studies
published
up
to
5
January
2021,
reporting
multiple
attributed
origin.
According
PRISMA
guidelines,
we
included
total
16
papers
due
infections.
The
aim
this
review
is
investigate
treatment
modality
clinical
outcome
patients
well
identify
most
common
pathogens
involved
status
their
role,
microbiota,
onset
multidisciplinary
approach
essential
management
BAs.
Further
are
required
understand
better
development
Disease Markers,
Journal Year:
2021,
Volume and Issue:
2021, P. 1 - 12
Published: Dec. 13, 2021
Background.
MicroRNAs
(miRNA)
identified
as
critical
molecular
regulators
for
bone
development,
function,
and
modeling/remodeling
process
could
be
predictable
osteoporotic
fractures
in
postmenopausal
elderly
women.
Aim.
The
potential
diagnostic
role
of
circulating
miRNAs,
miR-148a
miR-122-5p,
the
pathogenesis
osteoporosis
its
association
with
markers,
hypercortisolism,
vitamin
D
deficiency
were
explored
women
osteoporosis.
Methods.
A
total
120
aged
50–80
years
old
recruited
this
study,
which
only
100
eligible
amenorrhea
at
least
12
consecutive
months
or
surgical
menopause
participated
study.
Based
upon
mineral
density
(BMD)
measurements,
participants
classified
according
into
two
groups:
normal
(
n=45
;
T
score
≥-1.0)
n=55T
score:
≤-2.5).
Circulating
estimated
by
real-time
RT-PCR
analysis.
In
addition,
colorimetrically
ELISA
immune
assay
estimated.
miR-148a,
cortisol,
diagnosis
was
predicted
using
analysis
respective
area
under
receiver
operating
characteristic
curve
(AUC-ROC).
Results.
expressed
level
significantly
increased
miR-122-5p
decreased
serum
patients
compared
to
healthy
controls.
a
significant
increase
levels
s-BAP,
CTx
decrease
T-BMD,
OC,
s-Ca
also
identified.
All
parameters
correlated
fracture
risk
parameters;
BMD,
T
lumbar
spine
(L2-L4).
Thus,
data
showed
AUC
cut
off
values
(miR-148a;
0.876,
miR-122-5p;
0.761)
best
evaluated
clinical
that
0.748
cortisol
0.635
values,
respectively,
reported
prediction
diagnosis.
Conclusion.
miRNAs
changes
both
status
are
associated
loss
circulation
alone
combination
might
considered
biomarkers
women;
however,
more
studies
recommended.
Journal of Inflammation Research,
Journal Year:
2021,
Volume and Issue:
Volume 14, P. 5337 - 5347
Published: Oct. 1, 2021
Purpose:
Clinically,
it
is
challenging
to
manage
diabetic
patients
with
periodontitis.
Biochemically,
both
involve
a
wide
range
of
inflammatory/collagenolytic
conditions
which
exacerbate
each
other
in
"bi-directional
manner."
However,
standard
treatments
for
this
type
periodontitis
rely
on
reducing
the
bacterial
burden
and
less
controlling
hyper-inflammation/excessive-collagenolysis.
Thus,
there
crucial
need
new
therapeutic
strategies
modulate
excessive
host
response
promote
enhanced
resolution
inflammation.
The
aim
current
study
evaluate
impact
novel
chemically-modified
curcumin
2.24
(CMC2.24)
inflammatory
rats.
Methods:
Type
I
diabetes
was
induced
by
streptozotocin
injection;
periodontal
breakdown
then
results
as
complication
uncontrolled
hyperglycemia.
Non-diabetic
rats
served
controls.
CMC2.24,
or
vehicle-alone,
administered
oral
gavage
daily
3
weeks
diabetics.
Micro-CT
used
analyze
morphometric
changes
quantify
bone
loss.
MMPs
were
analyzed
gelatin
zymography.
Cell
function
examined
cell
migration
assay,
cytokines
resolvins
measured
ELISA.
Results:
In
severe
disease
model,
administration
pleiotropic
CMC2.24
found
normalize
accumulation
impaired
chemotactic
activity
macrophages
peritoneal
exudates,
significantly
decrease
MMP-9
pro-inflammatory
near
normal
levels,
markedly
increase
resolvin
D
1
(RvD
)
levels
thioglycolate-elicited
exudates
(tPE).
Similar
effects
RvD
observed
non-elicited
resident
washes
(rPW).
Regarding
clinical
relevance,
inhibited
loss
alveolar
height,
volume
mineral
density
(ie,
diabetes-induced
osteoporosis).
Conclusion:
conclusion,
treating
hyperglycemic
(a
tri-ketonic
phenylaminocarbonyl
curcumin)
promotes
local
systemic
inflammation,
reduces
loss,
addition
suppressing
collagenolytic
cytokines,
suggesting
strategy
complicated
chronic
diseases.
Keywords:
hyperglycemia,
periodontitis,
matrix
metalloproteinases,
resolvins,
host-modulatory
therapy